Canada is currently experiencing a nationwide shortage of some commonly used prescription pain medications. Health Canada issued a notice on July 18 confirming that drugs containing acetaminophen with codeine or oxycodone are in limited supply. These medications are often used to manage moderate to severe pain. Products affected include combinations of acetaminophen with oxycodone (sold under brand names like Percocet) and acetaminophen with codeine (such as Tylenol No. 3). Other impacted formulations include Teva-Oxycocet, Teva-Lenoltec No. 1 to 4, and Rivacocet.
Pharmaceutical companies such as Teva Canada Ltd., Laboratoire Riva Inc., and Pharmascience Inc. have cited manufacturing disruptions and increased demand as reasons for the shortage. To manage the shortage, pharmacists across the country have been dispensing limited quantities. Sadaf Faisal, senior director of professional affairs at the Canadian Pharmacists Association (CPA), told Global News that pharmacists currently supply only a 30-day supply in some cases due to low availability.
Some pharmacists are also reaching out to other pharmacies to source additional stock. When will supply resume? The CPA expects the shortage to last until early August, with a significant resupply anticipated at that time. In the meantime, Health Canada urges patients to speak with their doctors or pharmacists if they are affected. Alternative pain relief options may be available, but any change in medication requires physician approval due to federal drug regulations.
Canadians are advised to use only licensed pharmacies and avoid unverified online sellers. Health Canada warns that unregulated sources may sell products lacking active ingredients or containing dangerous substances.